Inhibition of macrophages inflammasome activation via autophagic degradation of HMGB1 by EGCG ameliorates HBV-induced liver injury and fibrosis
BackgroundLiver fibrosis is a reversible wound-healing response that can lead to end-stage liver diseases without effective treatment, in which HBV infection is a major cause. However, the underlying mechanisms for the development of HBV-induced fibrosis remains elusive, and efficacious therapies fo...
Main Authors: | Minjing He, Tianhao Chu, Ziteng Wang, Ying Feng, Runhan Shi, Muyang He, Siheng Feng, Lin Lu, Chen Cai, Fang Fang, Xuemin Zhang, Yi Liu, Bo Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1147379/full |
Similar Items
-
HMGB1 mediates cognitive impairment caused by the NLRP3 inflammasome in the late stage of traumatic brain injury
by: Si-Wei Tan, et al.
Published: (2021-10-01) -
HMGB1 Increases IL-1β Production in Vascular Smooth Muscle Cells via NLRP3 Inflammasome
by: Eun Jung Kim, et al.
Published: (2018-03-01) -
Repositioning Linagliptin for the Mitigation of Cadmium-Induced Testicular Dysfunction in Rats: Targeting HMGB1/TLR4/NLRP3 Axis and Autophagy
by: Hany H. Arab, et al.
Published: (2022-07-01) -
Ethyl Pyruvate Attenuates Microglial NLRP3 Inflammasome Activation via Inhibition of HMGB1/NF-κB/miR-223 Signaling
by: Melis Olcum, et al.
Published: (2021-05-01) -
Suppression of Glucagon-Like Peptide-1 Release by Inhibition of Intestinal NLRP3 Inflammasome Activation in Asc–/– and Nlrp3–/– Mice
by: Yu Chen, et al.
Published: (2019-10-01)